Aptargroup ATR
NYSE ATR
$134.80 +1.84 (+1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aptargroup (ATR) Current Deferred Revenue (2010 - 2011)

Aptargroup (ATR) posted quarterly Current Deferred Revenue of $17.2 million for Q4 2011, up 8.63% year-over-year from $15.8 million in Q4 2010, and up 8.63% on a QoQ basis from $15.8 million in Q4 2010.

Aptargroup (ATR) Current Deferred Revenue (2010 - 2011) Analysis & Trends

Aptargroup has reported Current Deferred Revenue for 2 years, with the latest figure at $17.2 million in Q4 2011.

  • Current Deferred Revenue for Q4 2011 came in at $17.2 million, up 8.63% year-over-year; the trailing twelve-month figure through Dec 2011 was $17.2 million (up 8.63% YoY), and the FY2011 annual result was $17.2 million, up 8.63% from the prior year.
  • Current Deferred Revenue improved to $17.2 million in Q4 2011, from $15.8 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $17.2 million in Q4 2011 and troughed at $15.8 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Aptargroup 8.58 Bn 8.38 Bn 365.52 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 17.16 Mn
Dec 31, 2010 15.80 Mn